We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Tick Saliva Drug Could Prevent HIV-Linked Heart Disease

News   Aug 30, 2017 | Original Story from the University of Pittsburgh Schools of Health Sciences

 
Ixolaris to Treat HIV-linked Heart Disease
 
 
Advertisement
 

RELATED ARTICLES

Lessons Learnt From the First Known Community-acquired COVID-19 Case in the U.S.

News

When UC Davis announced the first case of community transmission of COVID-19 in the U.S. on Feb. 26, it solved a medical mystery at the hospital and led to important changes to the U.S. Centers for Disease Control and Prevention (CDC) guidelines for novel coronavirus testing.

READ MORE

Heart-on-a-Chip Mimics Cardiac Ischemia

News

Researchers led by biomedical engineers at Tufts University invented a microfluidic chip containing cardiac cells that is capable of mimicking hypoxic conditions following a heart attack - specifically when an artery is blocked in the heart and then unblocked after treatment.

READ MORE

Hidden Messages in Protein Blueprints

News

Scientists have identified a new control mechanism that enables stem cells to adapt their activity in emergency situations.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE